Evidence Library
Filter by drug, type, year, and open access.
Showing 401–427 of 427 results
- Zaleplon improves sleep without producing rebound effects in outpatients with insomnia — International Clinical Psychopharmacology (2000)• Drug: zaleplonDOIPMID
- Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial — Archives of General Psychiatry (1999)• Drug: phenelzineOpen accessDOIPMIDPMCID
- Treatment of Social Phobia With Gabapentin — Journal of Clinical Psychopharmacology (1999)• Drug: gabapentinDOI
- A 14-month randomized clinical trial of treatment strategies for ADHD (MTA Cooperative Group) — Archives of General Psychiatry (1999)• Drug: methylphenidatePMID
- Managing Antipsychotic-Induced Acute and Tardive Dystonia — Drug Safety (1998)• Drug: benztropineDOI
- Managing Antipsychotic-Induced Acute and Tardive Dystonia — Drug Safety (1998)• Drug: trihexyphenidylDOI
- Haloperidol serum concentrations and D2 receptor occupancy during low‑dose treatment with haloperidol decanoate — International Clinical Psychopharmacology (1997)• Drug: haloperidolDOI
- Sertraline versus clomipramine in pediatric obsessive-compulsive disorder — Journal of the American Academy of Child and Adolescent Psychiatry (1997)• Drug: clomipramineDOIPMID
- Haloperidol and reduced haloperidol plasma concentrations after a loading dose regimen with haloperidol decanoate — Progress in Neuro‑Psychopharmacology and Biological Psychiatry (1996)• Drug: haloperidolDOI
- A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients — Psychopharmacology (1996)• Drug: mirtazapinePMID
- D2 dopamine receptor occupancy during low‑dose treatment with haloperidol decanoate — American Journal of Psychiatry (1995)• Drug: haloperidolDOI
- Disposition of haloperidol and reduced haloperidol plasma levels after single‑dose haloperidol decanoate administration — Human Psychopharmacology: Clinical and Experimental (1995)• Drug: haloperidolDOI
- Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study — The British Journal of Psychiatry (1995)• Drug: paroxetineDOIPMID
- D2 dopamine receptor occupancy during low‑dose treatment with haloperidol decanoate — American Journal of Psychiatry (1995)• Drug: haloperidol-decanoateDOI
- Review of carbamazepine-induced hyponatremia. — Progress in Neuro-Psychopharmacology & Biological Psychiatry (1994)• Drug: carbamazepineDOIPMID
- Antidepressants for the treatment of generalized anxiety disorder: placebo-controlled comparison of imipramine, trazodone, and diazepam — Archives of General Psychiatry (1993)• Drug: diazepamDOIPMID
- Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial — Archives of General Psychiatry (1992)• Drug: fluoxetinePMID
- Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment — Archives of General Psychiatry (1988)• Drug: alprazolamDOIPMID
- Neuroleptic-induced akathisia: Propranolol versus benztropine — Biological Psychiatry (1988)• Drug: propranololDOI
- Clinical pharmacokinetics of haloperidol decanoate. Comparison with other prolonged-action neuroleptics. — L'Encephale (1987)• Drug: haloperidolPMID
- Maprotiline Treatment in Depression — Archives of General Psychiatry (1986)• Drug: maprotilineDOI
- Clinical pharmacokinetics of carbamazepine — Clinical Pharmacokinetics (1978)• Drug: carbamazepineDOI
- Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism — American Journal of Psychiatry (1976)• Drug: amantadineDOI
- Oxazepam-protriptyline: a double-blind phase II evaluation of the efficacy and safety of the combination versus placebo in neurotic, depressed and anxious psychiatric outpatients — Current Therapeutic Research, Clinical and Experimental (1975)• Drug: protriptylinePMID
- A Double-Blind Study of Amantadine Hydrochloride versus Benztropine Mesylate in Drug-Induced Parkinsonism — European Neurology (1974)• Drug: amantadineDOI
- Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial — British Medical Journal (1973)• Drug: fluphenazineOpen accessDOIPMIDPMCID
- Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial — British Medical Journal (1973)• Drug: fluphenazine-decanoateOpen accessDOIPMIDPMCID